{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:35:30Z","timestamp":1794897330898,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA274738"],"award-info":[{"award-number":["R01CA274738"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21CA270872"],"award-info":[{"award-number":["R21CA270872"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR 21-43673 CAR"],"award-info":[{"award-number":["DMR 21-43673 CAR"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-59278-0","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T16:22:05Z","timestamp":1745338925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Injectable extracellular vesicle hydrogels with tunable viscoelasticity for depot vaccine"],"prefix":"10.1038","volume":"16","author":[{"given":"Rimsha","family":"Bhatta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7794-0661","authenticated-orcid":false,"given":"Joonsu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9723-2259","authenticated-orcid":false,"given":"Yang","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-441X","authenticated-orcid":false,"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1157-8786","authenticated-orcid":false,"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"59278_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-3-030-67171-6_2","volume":"97","author":"T Kang","year":"2021","unstructured":"Kang, T., Atukorala, I. & Mathivanan, S. Biogenesis of Extracellular Vesicles. Subcell. Biochem 97, 19\u201343 (2021).","journal-title":"Subcell. Biochem"},{"key":"59278_CR2","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann, I. K., Wood, M. J. A. & Fuhrmann, G. Extracellular vesicles as a next-generation drug delivery platform. Nat. Nanotechnol. 16, 748\u2013759 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"59278_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung, S., Perocheau, D., Touramanidou, L. & Baruteau, J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun. Signal 19, 47\u201347 (2021).","journal-title":"Cell Commun. Signal"},{"key":"59278_CR4","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"59278_CR5","doi-asserted-by":"publisher","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","volume":"16","author":"R Tenchov","year":"2022","unstructured":"Tenchov, R. et al. Exosomes\u2500Nature\u2019s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. ACS Nano 16, 17802\u201317846 (2022).","journal-title":"ACS Nano"},{"key":"59278_CR6","doi-asserted-by":"publisher","first-page":"9355","DOI":"10.2147\/IJN.S281890","volume":"15","author":"J Shao","year":"2020","unstructured":"Shao, J., Zaro, J. & Shen, Y. Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate. Int. J. Nanomed. 15, 9355\u20139371 (2020).","journal-title":"Int. J. Nanomed."},{"key":"59278_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-pharmtox-010814-124630","volume":"55","author":"B Gy\u00f6rgy","year":"2015","unstructured":"Gy\u00f6rgy, B., Hung, M. E., Breakefield, X. O. & Leonard, J. N. Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu. Rev. Pharm. Toxicol. 55, 439\u2013464 (2015).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"59278_CR8","doi-asserted-by":"publisher","first-page":"aav8521","DOI":"10.1126\/scitranslmed.aav8521","volume":"11","author":"OPB Wiklander","year":"2019","unstructured":"Wiklander, O. P. B., Brennan, M., L\u00f6tvall, J., Breakefield, X. O. & El Andaloussi, S. Advances in therapeutic applications of extracellular vesicles. Sci. Transl. Med. 11, aav8521 (2019).","journal-title":"Sci. Transl. Med."},{"key":"59278_CR9","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470\u20131476 (2008).","journal-title":"Nat. Cell Biol."},{"key":"59278_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.molmed.2014.03.002","volume":"20","author":"P Vader","year":"2014","unstructured":"Vader, P., Breakefield, X. O. & Wood, M. J. Extracellular vesicles: emerging targets for cancer therapy. Trends Mol. Med. 20, 385\u2013393 (2014).","journal-title":"Trends Mol. Med."},{"key":"59278_CR11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1101\/gad.192351.112","volume":"26","author":"C D\u2019Souza-Schorey","year":"2012","unstructured":"D\u2019Souza-Schorey, C. & Clancy, J. W. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 26, 1287\u20131299 (2012).","journal-title":"Genes Dev."},{"key":"59278_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13287-024-03952-5","volume":"15","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Exosomes as promising bioactive materials in the treatment of spinal cord injury. Stem Cell Res. Ther. 15, 335 (2024).","journal-title":"Stem Cell Res. Ther."},{"key":"59278_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2217\/rme.11.35","volume":"6","author":"RC Lai","year":"2011","unstructured":"Lai, R. C., Chen, T. S. & Lim, S. K. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen. Med. 6, 481\u2013492 (2011).","journal-title":"Regen. Med."},{"key":"59278_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.scr.2011.01.001","volume":"6","author":"L Timmers","year":"2011","unstructured":"Timmers, L. et al. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 6, 206\u2013214 (2011).","journal-title":"Stem Cell Res."},{"key":"59278_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ymthe.2016.09.001","volume":"25","author":"C Wang","year":"2017","unstructured":"Wang, C. et al. Macrophage-Derived mir-155-Containing Exosomes Suppress Fibroblast Proliferation and Promote Fibroblast Inflammation during Cardiac Injury. Mol. Ther. 25, 192\u2013204 (2017).","journal-title":"Mol. Ther."},{"key":"59278_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12648","volume":"87","author":"S He","year":"2018","unstructured":"He, S. et al. Endothelial extracellular vesicles modulate the macrophage phenotype: Potential implications in atherosclerosis. Scand. J. Immunol. 87, e12648 (2018).","journal-title":"Scand. J. Immunol."},{"key":"59278_CR17","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1161\/CIRCULATIONAHA.111.044164","volume":"125","author":"U Hofmann","year":"2012","unstructured":"Hofmann, U. et al. Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 125, 1652\u20131663 (2012).","journal-title":"Circulation"},{"key":"59278_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","volume":"115","author":"J Weirather","year":"2014","unstructured":"Weirather, J. et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte\/macrophage differentiation. Circ. Res. 115, 55\u201367 (2014).","journal-title":"Circ. Res."},{"key":"59278_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-023-00266-6","volume":"43","author":"T Manzoor","year":"2023","unstructured":"Manzoor, T. et al. Extracellular vesicles derived from mesenchymal stem cells \u2014 a novel therapeutic tool in infectious diseases. Inflamm. Regen. 43, 17 (2023).","journal-title":"Inflamm. Regen."},{"key":"59278_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","volume":"13","author":"M Kou","year":"2022","unstructured":"Kou, M. et al. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis. 13, 580 (2022).","journal-title":"Cell Death Dis."},{"key":"59278_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-016-0068-0","volume":"20","author":"W Nassar","year":"2016","unstructured":"Nassar, W. et al. Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater. Res. 20, 21 (2016).","journal-title":"Biomater. Res."},{"key":"59278_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/sctm.19-0202","volume":"9","author":"M Kabat","year":"2020","unstructured":"Kabat, M., Bobkov, I., Kumar, S. & Grumet, M. Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range? Stem Cells Transl. Med. 9, 17\u201327 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"59278_CR23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jcyt.2023.04.007","volume":"25","author":"A Duong","year":"2023","unstructured":"Duong, A., Parmar, G., Kirkham, A. M., Burger, D. & Allan, D. S. Registered clinical trials investigating treatment with cell-derived extracellular vesicles: a scoping review. Cytotherapy 25, 939\u2013945 (2023).","journal-title":"Cytotherapy"},{"key":"59278_CR24","doi-asserted-by":"publisher","first-page":"115856","DOI":"10.1016\/j.bios.2023.115856","volume":"245","author":"T Zhang","year":"2024","unstructured":"Zhang, T. et al. CRISPR-Cas12a powered hybrid nanoparticle for extracellular vesicle aggregation and in-situ microRNA detection. Biosens. Bioelectron. 245, 115856 (2024).","journal-title":"Biosens. Bioelectron."},{"key":"59278_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","volume":"8","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Engineered exosomes from different sources for cancer-targeted therapy. Sig. Transduct. Target Ther. 8, 124 (2023).","journal-title":"Sig. Transduct. Target Ther."},{"key":"59278_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12951-024-02298-7","volume":"22","author":"Q Yang","year":"2024","unstructured":"Yang, Q. et al. Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application. J. Nanobiotechnol. 22, 41 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"59278_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12951-024-02452-1","volume":"22","author":"X Xue","year":"2024","unstructured":"Xue, X. et al. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments. J. Nanobiotechnol. 22, 196 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"59278_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03456-5","volume":"24","author":"C Qin","year":"2024","unstructured":"Qin, C. et al. The systematic role of pancreatic cancer exosomes: distant communication, liquid biopsy and future therapy. Cancer Cell Int. 24, 264 (2024).","journal-title":"Cancer Cell Int."},{"key":"59278_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj7002","volume":"8","author":"S Kamerkar","year":"2022","unstructured":"Kamerkar, S. et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity. Sci. Adv. 8, eabj7002 (2022).","journal-title":"Sci. Adv."},{"key":"59278_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12332","volume":"12","author":"J Johnson","year":"2023","unstructured":"Johnson, J. et al. First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing. J. Extracell. Vesicles 12, e12332 (2023).","journal-title":"J. Extracell. Vesicles"},{"key":"59278_CR31","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.3389\/fimmu.2018.02481","volume":"9","author":"M Dionisi","year":"2018","unstructured":"Dionisi, M. et al. Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells. Front. Immunol. 9, 2481 (2018).","journal-title":"Front. Immunol."},{"key":"59278_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1158\/2326-6066.CIR-13-0112-T","volume":"2","author":"A Rughetti","year":"2014","unstructured":"Rughetti, A. et al. Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing. Cancer Immunol. Res. 2, 177\u2013186 (2014).","journal-title":"Cancer Immunol. Res."},{"key":"59278_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/2326-6066.CIR-14-0177","volume":"3","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS\/STING signaling. Cancer Immunol. Res. 3, 196\u2013205 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"59278_CR34","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.7150\/jca.59391","volume":"12","author":"R Luo","year":"2021","unstructured":"Luo, R. et al. Emerging Diagnostic Potential of Tumor-derived Exosomes. J. Cancer 12, 5035\u20135045 (2021).","journal-title":"J. Cancer"},{"key":"59278_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01278-3","volume":"19","author":"Z Xu","year":"2020","unstructured":"Xu, Z., Zeng, S., Gong, Z. & Yan, Y. Exosome-based immunotherapy: a promising approach for cancer treatment. Mol. Cancer 19, 160 (2020).","journal-title":"Mol. Cancer"},{"key":"59278_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.biomaterials.2016.09.031","volume":"111","author":"M Morishita","year":"2016","unstructured":"Morishita, M., Takahashi, Y., Matsumoto, A., Nishikawa, M. & Takakura, Y. Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA. Biomaterials 111, 55\u201365 (2016).","journal-title":"Biomaterials"},{"key":"59278_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00959-4","volume":"20","author":"J Rezaie","year":"2022","unstructured":"Rezaie, J., Feghhi, M. & Etemadi, T. A review on exosomes application in clinical trials: perspective, questions, and challenges. Cell Commun. Signal. 20, 145 (2022).","journal-title":"Cell Commun. Signal."},{"key":"59278_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-3-10","volume":"3","author":"B Escudier","year":"2005","unstructured":"Escudier, B. et al. Vaccination of metastatic melanoma patients with autologous dendritic cell derived-exosomes: results of thefirst phase I clinical trial. J. Transl. Med. 3, 10 (2005).","journal-title":"J. Transl. Med."},{"key":"59278_CR39","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/mt.2008.1","volume":"16","author":"S Dai","year":"2008","unstructured":"Dai, S. et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol. Ther. 16, 782\u2013790 (2008).","journal-title":"Mol. Ther."},{"key":"59278_CR40","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/jcm10040711","volume":"10","author":"BC Lee","year":"2021","unstructured":"Lee, B. C., Kang, I. & Yu, K. R. Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes. J. Clin. Med. 10, 711 (2021).","journal-title":"J. Clin. Med."},{"key":"59278_CR41","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3727\/096368913X667709","volume":"23","author":"X Liang","year":"2014","unstructured":"Liang, X., Ding, Y., Zhang, Y., Tse, H.-F. & Lian, Q. Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives. Cell Transplant. 23, 1045\u20131059 (2014).","journal-title":"Cell Transplant."},{"key":"59278_CR42","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1080\/08820139.2020.1712416","volume":"49","author":"M Jafarinia","year":"2020","unstructured":"Jafarinia, M., Alsahebfosoul, F., Salehi, H., Eskandari, N. & Ganjalikhani-Hakemi, M. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy. Immunological Investig. 49, 758\u2013780 (2020).","journal-title":"Immunological Investig."},{"key":"59278_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12134","volume":"10","author":"MM Shi","year":"2021","unstructured":"Shi, M. M. et al. Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles. J. Extracell. Vesicles 10, e12134 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"59278_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12929-024-01000-1","volume":"31","author":"B Zhang","year":"2024","unstructured":"Zhang, B., Sim, W. K., Shen, T. L. & Lim, S. K. Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines. J. Biomed. Sci. 31, 9 (2024).","journal-title":"J. Biomed. Sci."},{"key":"59278_CR45","doi-asserted-by":"publisher","first-page":"113790","DOI":"10.1016\/j.biopha.2022.113790","volume":"156","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q. et al. Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy. Biomed. Pharmacother. 156, 113790 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"59278_CR46","doi-asserted-by":"publisher","first-page":"e1319044","DOI":"10.1080\/2162402X.2017.1319044","volume":"6","author":"L Xiao","year":"2017","unstructured":"Xiao, L., Erb, U., Zhao, K., Hackert, T. & Z\u00f6ller, M. Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer. Oncoimmunology 6, e1319044 (2017).","journal-title":"Oncoimmunology"},{"key":"59278_CR47","doi-asserted-by":"publisher","first-page":"8977","DOI":"10.1021\/acsnano.8b02446","volume":"12","author":"YW Choo","year":"2018","unstructured":"Choo, Y. W. et al. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors. ACS Nano 12, 8977\u20138993 (2018).","journal-title":"ACS Nano"},{"key":"59278_CR48","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1182\/blood-2004-04-1578","volume":"105","author":"FL Willekens","year":"2005","unstructured":"Willekens, F. L. et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 105, 2141\u20132145 (2005).","journal-title":"Blood"},{"key":"59278_CR49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/gels8060328","volume":"8","author":"Y Xie","year":"2022","unstructured":"Xie, Y. et al. Hydrogels for Exosome Delivery in Biomedical Applications. Gels 8, 328 (2022).","journal-title":"Gels"},{"key":"59278_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303822120","volume":"120","author":"J Tang","year":"2023","unstructured":"Tang, J. et al. A DNA-based hydrogel for exosome separation and biomedical applications. Proc. Natl Acad. Sci. 120, e2303822120 (2023).","journal-title":"Proc. Natl Acad. Sci."},{"key":"59278_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105586","volume":"9","author":"L Fan","year":"2022","unstructured":"Fan, L. et al. Exosomes\u2010loaded Electroconductive hydrogel synergistically promotes tissue repair after spinal cord injury via Immunoregulation and enhancement of myelinated axon growth. Adv. Sci. 9, 2105586 (2022).","journal-title":"Adv. Sci."},{"key":"59278_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202100312","volume":"11","author":"J Tang","year":"2022","unstructured":"Tang, J. et al. Injection\u2010free delivery of MSC\u2010derived extracellular vesicles for myocardial infarction therapeutics. Adv. Healthc. Mater. 11, 2100312 (2022).","journal-title":"Adv. Healthc. Mater."},{"key":"59278_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43914-8","volume":"14","author":"R Bhatta","year":"2023","unstructured":"Bhatta, R. et al. Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines. Nat. Commun. 14, 8047 (2023).","journal-title":"Nat. Commun."},{"key":"59278_CR54","doi-asserted-by":"publisher","first-page":"100522","DOI":"10.1016\/j.mtbio.2022.100522","volume":"18","author":"Y Ju","year":"2023","unstructured":"Ju, Y., Hu, Y., Yang, P., Xie, X. & Fang, B. Extracellular vesicle-loaded hydrogels for tissue repair and regeneration. Mater. Today Bio 18, 100522 (2023).","journal-title":"Mater. Today Bio"},{"key":"59278_CR55","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1039\/D1NR01314A","volume":"13","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. Cell-free exosome-laden scaffolds for tissue repair. Nanoscale 13, 8740\u20138750 (2021).","journal-title":"Nanoscale"},{"key":"59278_CR56","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.1155106","volume":"320","author":"ST Laughlin","year":"2008","unstructured":"Laughlin, S. T., Baskin, J. M., Amacher, S. L. & Bertozzi, C. R. In Vivo Imaging of Membrane-Associated Glycans in Developing Zebrafish. Science 320, 664\u2013667 (2008).","journal-title":"Science"},{"key":"59278_CR57","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1038\/nprot.2007.422","volume":"2","author":"ST Laughlin","year":"2007","unstructured":"Laughlin, S. T. & Bertozzi, C. R. Metabolic labeling of glycans with azido sugars and subsequent glycan-profiling and visualization via Staudinger ligation. Nat. Protoc. 2, 2930 (2007).","journal-title":"Nat. Protoc."},{"key":"59278_CR58","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41557-020-00587-w","volume":"12","author":"H Wang","year":"2020","unstructured":"Wang, H. & Mooney, D. J. Metabolic glycan labelling for cancer-targeted therapy. Nat. Chem. 12, 1102\u20131114 (2020).","journal-title":"Nat. Chem."},{"key":"59278_CR59","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nchembio.2297","volume":"13","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Selective in vivo metabolic cell-labeling-mediated cancer targeting. Nat. Chem. Biol. 13, 415 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"59278_CR60","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/s41563-020-0680-1","volume":"19","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. Metabolic labeling and targeted modulation of dendritic cells. Nat. Mater. 19, 1244\u20131252 (2020).","journal-title":"Nat. Mater."},{"key":"59278_CR61","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1002\/anie.201509601","volume":"55","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. Targeted Ultrasound-Assisted Cancer-Selective Chemical Labeling and Subsequent Cancer Imaging using Click Chemistry. Angew. Chem. Int. Ed. 55, 5452\u20135456 (2016).","journal-title":"Angew. Chem. Int. Ed."},{"key":"59278_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40886-7","volume":"14","author":"J Han","year":"2023","unstructured":"Han, J. et al. Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine. Nat. Commun. 14, 5049 (2023).","journal-title":"Nat. Commun."},{"key":"59278_CR63","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1073\/pnas.1516524113","volume":"113","author":"R Xie","year":"2016","unstructured":"Xie, R. et al. In vivo metabolic labeling of sialoglycans in the mouse brain by using a liposome-assisted bioorthogonal reporter strategy. Proc. Natl Acad. Sci. 113, 5173\u20135178 (2016).","journal-title":"Proc. Natl Acad. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59278-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59278-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59278-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T04:01:33Z","timestamp":1745726493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59278-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59278"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59278-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"31 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.W. and R.B. filed a patent application for the extracellular vesicle hydrogel technology. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3781"}}